Author:
Kutscher Scott,Juang Christine
Abstract
ABSTRACTObjectiveThis article provides an overview of the current definitions, diagnostic tools, and overall management of insomnia.Latest DevelopmentsThe treatment of insomnia has shifted over time, with a growing emphasis on nonpharmacologic therapies as a first-line intervention and the leveraging of technology to aid in the dissemination of these therapies. With this evolution, the definition of insomnia has changed to reflect a common treatment pathway. As pharmacologic treatment options have increased, so has concern about the dangerous short-term and long-term adverse effects of these treatment options.Essential PointsInsomnia is a common disorder, frequently overlapping with other neurologic and psychiatric disorders, which can cause significant distress and disruption to patients’ lives. Nonpharmacologic therapies are highly effective and are now considered first-line treatments. Although efficacy is variable, numerous pharmacologic interventions are available, and many options come with considerable concern about adverse effects, particularly in populations over 65 years old.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Genetics (clinical),Neurology (clinical)
Reference76 articles.
1. Epidemiology of insomnia: what we know and what we still need to learn;Sleep Med Rev,2002
2. Societal costs of insomnia;Sleep Med Rev,2010
3. Insomnia disorder: state of the science and challenges for the future;J Sleep Res,2022
4. Practice parameters for behavioral treatment of bedtime problems and night wakings in infants and young children;Sleep,2006
5. Behavioral treatment of bedtime problems and night wakings in infants and young children;Sleep,2006
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Insomnia;Primary Care: Clinics in Office Practice;2024-06